FDA Grants Approval for Sodium Acetate ANDA220274 by Extrovis
The FDA has granted approval for ANDA220274, a sodium acetate product submitted by Extrovis.
Therapeutic Area
Therapeutic area intelligence for Injectable with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.